Yale to be Funded for Spine Treatment Study, Says Medtronic
by Yvonne Magtibay in Beauty & Wellness on Aug 08, 2011
Yale University will be given by Medtronic Inc. an amount of $2.5 million grant in order to accomplish an independent and ambitious review of the controversial spine treatment named Infuse Bone Graft’s effectiveness and safety.
The university is open to choose two teams from other organizations that will do the research and perform the data’s separate analyses. Within the terms of the agreement, Medtronic will be releasing to the university and later on the public on the description of participants of an unparalleled amount of clinical trial and some other information.
The agreement was decided when an article was published in the June issue of Spine Journal and found out that some studies on Infuse have failed to account serious complications, which came up in those trials. The studies were done by surgeons who had some strong economic connections with Medtronic. Additionally, the article also discovered that a lot of the studies were calculated in methods that will support Infuse rather than the given treatment to the controlled group.
The chief scientific officer, Richard Kuntz expressed that the executives have decided that there will be a review performed by the company separately, since it is obligatory to deal with the queries heaved by the study. This is in connection with the internal investigation that will be done by Medtronic since they have some disagreements with some of the results. Kuntz emphasized that their public trust was challenged.
Related Posts:
Very nice post. I just stumbled upon your blog and wanted to say that I have truly enjoyed surfing around your blog posts. In any case I’ll be subscribing to your rss feed and I hope you write again soon!